跳至主要内容
临床试验/NCT06161363
NCT06161363已完成不适用

Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus in a Hospital Internal Medicine Consultation

University Hospital, Toulouse1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2023年11月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
102
试验地点
1
主要终点
Non-compliance with hydroxychloroquine treatment

研究概览

简要总结

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them.

The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years
  • Patient with systemic lupus erythematosus
  • Treatment with PLAQUENIL for > 6 months with dosage of hydroxychloroquinemia planned during the consultation.

排除标准

  • 未提供

结局指标

主要结局

Non-compliance with hydroxychloroquine treatment

时间窗: Day 0

to describe the non-compliance with hydroxychloroquine treatment with the Morisky Medication Adherence Scale

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Description of Compliance With Hydroxychloroquine... | 临床试验